Back to search results

Preoperative Hemodialysis Timing for End-Stage Kidney Disease (POD-ESKD) Pilot Trial

This study is looking at the best timing for hemodialysis (a treatment that filters your blood when your kidneys can't) before surgery for people with end-stage kidney disease (ESKD). Researchers want to see if it's possible and safe to compare two approaches: having hemodialysis on the same day as your surgery, or not having it on the same day. They will compare these two schedules to understand if they are equally safe and practical. You might be able to join if you are 18 or older, have ESKD, have been on hemodialysis for at least 90 days, and have a stable hemodialysis schedule. The study aims to see if these different timings lead to similar results regarding how long between hemodialysis and surgery, and if there are problems like electrolyte imbalances or needing extra hemodialysis.

Study design
This is an interventional pilot study with a planned enrollment of 30 participants. It will compare two different hemodialysis schedules before surgery.
What's involved
You will answer questions about your health up to 4 weeks before and 4 weeks after your surgical procedure. You will participate in the study for about 2 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 30-day postoperative outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07339202

Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial

Recruiting
NAAges 18+InterventionalTreatment
Stanford University
~30 participants
Updated 2026-06-11 on ClinicalTrials.gov
What's tested:Same-Day HemodialysisNo Same-Day Hemodialysis

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of hours from completion of the most recent preoperative hemodialysis session to entry into the operating room
Measured over up to 1 day
+1 more outcome measured

Conditions

Perioperative Management
End Stage Kidney Disease (ESRD)
Hemodialysis

Explore related trials

Chronic Kidney Disease, Stage 5

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Vikram Fielding-Singh, MD, JD · PRINCIPAL_INVESTIGATOR · Stanford University

Who to contact

Satvik Sharma
[email protected]
650-736-9368
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Fistula or graft creation, revision, or removal
Fistulogram
Peritoneal dialysis catheter placement or revision
Lower extremity angiogram (including femoral and iliac vessels)
Lower extremity bypass (including femoral and iliac vessels)
Lower extremity amputation

What this trial measures

  • Number of hours from completion of the most recent preoperative hemodialysis session to entry into the operating roomup to 1 day
  • Number of participants who experience electrolyte abnormalities or volume overload requiring additional unplanned hemodialysis, rescheduling / cancellation of the surgical procedure, or an unanticipated escalation of postoperative level of care.up to 1 day